Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte–colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit–GM, engraftment, and Day +100 hematopoietic graft function
Erin T. Alexander, Jeanne A. Towery, Ashley N. Miller, Cindy Kramer, Kathy R. Hogan, Jerry E. Squires, Robert K. Stuart, Luciano J. CostaVolume:
51
Year:
2011
Language:
english
Pages:
6
DOI:
10.1111/j.1537-2995.2011.03085.x
File:
PDF, 212 KB
english, 2011